ViroCarb is Drug Discovery in Canada that focus on critical unmet business. Founded in 2011. They cover business area such as developer, therapeutic molecule drug, viral infection, critical unmet therapeutic need, treatment, all HIV subtype, adenovirus, human T cell line, HIV clinical strain, multi-drug resistant strain, disease, hepatitis, varicella, influenza, parvovirus, researcher, these HIV model study, clinical trial.
2011
( 13 years old in 2024 )
Critical Unmet
-
1 Yonge Street
Suite 1801
Toronto, Ontario M5E 1W7
Canada
Private
developertherapeutic molecule drugviral infectioncritical unmet therapeutic needtreatmentall HIV subtypeadenovirushuman T cell lineHIV clinical strainmulti-drug resistant straindiseasehepatitisvaricellainfluenzaparvovirusresearcherthese HIV model studyclinical trial
* We use standard office opening hours in near ViroCarb's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
ViroCarb is Drug Discovery business from Canada that founded in 2011 (13 years old in 2024), ViroCarb business is focusing on Critical Unmet.
ViroCarb headquarter office and corporate office address is located in 1 Yonge Street Suite 1801 Toronto, Ontario M5E 1W7 Canada.
ViroCarb was founded in Canada.
In 2024, ViroCarb is currently focus on critical unmet sector.
Above is snippet of Google Trends for "critical unmet" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with ViroCarb, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
